Evidence map›Paper›PMID 37651921›Full record

ReviewHearing research2023

Research advances in cochlear pericytes and hearing loss.

Xiaorui Shi

Open access · hybridAbstract readReview
In one paragraph

Review in Hearing research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Insights Into Stria Vascular Function, Stria Immunity, and Age-Related Hearing Loss.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Xiaorui ShiDepartment of Otolaryngology/Head & Neck Surgery, Oregon Hearing Research Center (NRC04), Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA. Electronic address: shix@ohsu.edu.
Oregon Health & Science University · US

Funding

The role of vascular endothelial growth factor signaling in normal hearing andaging-related cochlear atrophyR01DC018534 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Xiaorui Shi · 2020 to 2026
$2.6M
Strial vascular pathology from acoustic traumaR01DC015781 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI SHI, XIAORUI · 2017 to 2021
$2.0M
Fibrovascular coupling in the cochlea and pericyte recruitment after noiseR01DC010844 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI SHI, XIAORUI · 2010 to 2014
$1.9M
Cochlear angiogenesisR21DC016157 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI SHI, XIAORUI · 2017 to 2018
$516k
NIDCD NIH HHS R01 DC010844NIDCD NIH HHS R01 DC015781NIDCD NIH HHS R01 DC018534NIDCD NIH HHS R21 DC016157
6 · The paper itself

Abstract

Pericytes are specialized mural cells surrounding endothelial cells in microvascular beds. They play a role in vascular development, blood flow regulation, maintenance of blood-tissue barrier integrity, and control of angiogenesis, tissue fibrosis, and wound healing. In recent decades, understanding of the critical role played by pericytes in retina, brain, lung, and kidney has seen significant progress. The cochlea contains a large population of pericytes. However, the role of cochlear pericytes in auditory pathophysiology is, by contrast, largely unknown. The present review discusses recent progress in identifying cochlear pericytes, mapping their distribution, and defining their role in regulating blood flow, controlling the blood-labyrinth barrier (BLB) and angiogenesis, and involvement in different types of hearing loss.

Indexed as

DeafnessHearing LossCochleaEndothelial CellsHumansPericytesAngiogenesisBlood flow regulationEndothelial barrierHearing lossPericyte

Identifiers

PMID37651921
PMCPMC10538405
OpenAlexW4385998035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.